First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
Clinical trial NCT06877650 · RECRUITING
Trial details
- NCT number
- NCT06877650
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-11
- Primary completion
- 2028-03-30
- Enrollment
- 436
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.